Remove 2014 Remove Doctors Remove Healthcare
article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

The healthcare sector has seen a few developments over the years. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. Now, the organization is looking at opening over 500 to 700 new doctors’ offices in collaboration with Walgreens by 2025. Wondering what that is?

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. This class-action litigation specifically focused on a 2011 licensing agreement between the two companies. These actions allegedly led to the extension of Novartis’ patents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Whistleblower gets $250m as Biogen settles US kickbacks case

pharmaphorum

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. That resulted in false claims for payment being submitted to the government healthcare programs Medicare and Medicaid, it alleged.

article thumbnail

Former Sanofi head Viehbacher to become Biogen CEO

pharmaphorum

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs. Biogen’s activity in multiple sclerosis.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The lengthy validation of defossilised organic chemicals and plastics for the healthcare sector will take several years. The path to real zero. PNAS 2022, Vol.

article thumbnail

A Leader’s Journey From Surgical Tech Sales To Startup Global Director With Jennifer McLaughlin

Evolve Your Success

She sits down with Samuel Adeyinka to discuss how this particular healthcare innovation does its wonders, especially for those dealing with chronic pain. She moved from the clinical side to the sales side of the operating room back in 2014 and joined a major device company. Her story is something that you want to tune in to.

Sales 130